Merke, Deborah P.
National Institutes of Health · Eunice Kennedy Shriver National Institute of Child Health and Human Development · National Institutes of Health Clinical Center
66 papers on CoChatORCID 0000-0002-3746-0460
Most cited papers
- Verified
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
Bornstein, S. R., Allolio, B., Arlt, W., Barthel, A., Don-Wauchope, A., Hammer, G. D., Husebye, E. S., Merke, D. P., Murad, M. H., Stratakis, C. A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism
Adrenal Hormones and DisordersHormonal Regulation and Hypertension
Cited by 1,769
- Verified
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society Clinical Practice Guideline.
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism
Sexual Differentiation and DisordersAdrenal Hormones and Disorders
Cited by 1,468
- Verified
Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism
Sexual Differentiation and DisordersAdrenal Hormones and Disorders
Cited by 1,234
- Verified
Congenital adrenal hyperplasia
El-Maouche, D., Arlt, W., & Merke, D. P. (2017) · The Lancet
Sexual Differentiation and DisordersAdrenal Hormones and Disorders
Cited by 669
- Verified
Congenital adrenal hyperplasia.
Merke, D. P., & Bornstein, S. R. (2005) · The Lancet
Sexual Differentiation and DisordersAdrenal Hormones and Disorders
Cited by 628
- Verified
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews
Sexual Differentiation and DisordersAdrenal Hormones and Disorders
Cited by 556
- Verified
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Merke, D. P., & Auchus, R. J. (2020) · New England Journal of Medicine
Sexual Differentiation and DisordersAdrenal Hormones and Disorders
Cited by 341
- Verified
Modified-release hydrocortisone to provide circadian cortisol profiles
Debono, M., Ghobadi, C., Rostami-Hodjegan, A., Huatan, H., Campbell, M. J., Newell-Price, J., Darzy, K., Merke, D. P., Arlt, W., & Ross, R. J. (2009) · The Journal of Clinical Endocrinology & Metabolism
Adrenal Hormones and DisordersStress Responses and Cortisol
Cited by 322
- Verified
Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia
Finkielstain, G. P., Kim, M. S., Sinaii, N., Nishitani, M., Van Ryzin, C., Hill, S. C., Reynolds, J. C., Hanna, R. M., & Merke, D. P. (2012) · The Journal of Clinical Endocrinology & Metabolism
Sexual Differentiation and DisordersAdrenal Hormones and Disorders
Cited by 313
- Verified
Puberty-related influences on brain development
Giedd, J. N., Clasen, L. S., Lenroot, R., Greenstein, D., Wallace, G. L., Ordaz, S., Molloy, E. A., Blumenthal, J. D., Tossell, J. W., Stayer, C., et al. (2006) · Molecular and Cellular Endocrinology
Sexual Differentiation and DisordersHypothalamic control of reproductive hormones
Cited by 300
- Verified
Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency.
Merke, D. P., Chrousos, G. P., Eisenhofer, G., Weise, M., Keil, M. F., Rogol, A. D., Van Wyk, J. J., & Bornstein, S. R. (2000) · New England Journal of Medicine
Sexual Differentiation and DisordersAdrenal Hormones and Disorders
Cited by 266
- Verified
Adrenal-Derived 11-Oxygenated 19-Carbon Steroids are the Dominant Androgens in Classic 21-Hydroxylase Deficiency
Turcu, A. F., Nanba, A. T., Chomic, R., Upadhyay, S. K., Giordano, T. J., Shields, J. J., Merke, D. P., Rainey, W. E., & Auchus, R. J. (2016) · European Journal of Endocrinology
Sexual Differentiation and DisordersAdrenal Hormones and Disorders
Cited by 231
- Verified
Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
Finkielstain, G. P., Chen, W., Mehta, S. P., Fujimura, F. K., Hanna, R. M., Van Ryzin, C., McDonnell, N. B., & Merke, D. P. (2011) · The Journal of Clinical Endocrinology & Metabolism
Sexual Differentiation and DisordersAdrenal Hormones and Disorders
Cited by 192
- Verified
Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia
Merke, D. P., Keil, M. F., Jones, J. V., Fields, J., Hill, S., & Cutler, G. B. (2000) · The Journal of Clinical Endocrinology & Metabolism
Sexual Differentiation and DisordersAdrenal Hormones and Disorders
Cited by 190
- Verified
A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia
Mallappa, A., Sinaii, N., Kumar, P., Whitaker, M. J., Daley, L.-A., Digweed, D., Eckland, D. J. A., Van Ryzin, C., Nieman, L. K., Arlt, W., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism
Sexual Differentiation and DisordersAdrenal Hormones and Disorders
Cited by 167
- Verified
Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications.
Charmandari, E., Weise, M., Bornstein, S. R., Eisenhofer, G., Keil, M. F., Chrousos, G. P., & Merke, D. P. (2002) · The Journal of Clinical Endocrinology & Metabolism
Sexual Differentiation and DisordersAdrenal Hormones and Disorders
Cited by 164
- Verified
Future Directions in the Study and Management of Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Merke, D. P., Bornstein, S. R., Avila, N. A., & Chrousos, G. P. (2002) · Annals of Internal Medicine
Sexual Differentiation and DisordersAdrenal Hormones and Disorders
Cited by 147
- Verified
Revisiting the prevalence of nonclassic congenital adrenal hyperplasia in US Ashkenazi Jews and Caucasians
Hannah-Shmouni, F., Morissette, R., Sinaii, N., Elman, M., Prezant, T. R., Chen, W., Pulver, A., & Merke, D. P. (2017) · Genetics in Medicine
Sexual Differentiation and DisordersAdrenal Hormones and Disorders
Cited by 141
- Verified
Management of adolescents with congenital adrenal hyperplasia
Merke, D. P., & Poppas, D. P. (2013) · The Lancet Diabetes & Endocrinology
Sexual Differentiation and DisordersAdrenal Hormones and Disorders
Cited by 134
- Verified
A pharmacokinetic and pharmacodynamic study of delayed‐ and extended‐release hydrocortisone (Chronocort TM ) vs. conventional hydrocortisone (Cortef TM ) in the treatment of congenital adrenal hyperplasia
Verma, S., VanRyzin, C., Sinaii, N., Kim, M. S., Nieman, L. K., Ravindran, S., Calis, K. A., Arlt, W., Ross, R. J., & Merke, D. P. (2010) · Clinical Endocrinology
Sexual Differentiation and DisordersAdrenal Hormones and Disorders
Cited by 126
- Verified
An oral multiparticulate, modified‐release, hydrocortisone replacement therapy that provides physiological cortisol exposure
Whitaker, M. J., Debono, M., Huatan, H., Merke, D. P., Arlt, W., & Ross, R. J. (2014) · Clinical Endocrinology
Adrenal Hormones and DisordersAdvanced Drug Delivery Systems
Cited by 121
- Verified
Management challenges and therapeutic advances in congenital adrenal hyperplasia
Mallappa, A., & Merke, D. P. (2022) · Nature Reviews Endocrinology
Sexual Differentiation and DisordersAdrenal Hormones and Disorders
Cited by 113
- Verified
Modified-Release Hydrocortisone in Congenital Adrenal Hyperplasia
Merke, D. P., Mallappa, A., Arlt, W., Brac de la Perriere, A., Lindén Hirschberg, A., Juul, A., Newell-Price, J., Perry, C. G., Prete, A., Rees, D. A., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism
Sexual Differentiation and DisordersAdrenal Hormones and Disorders
Cited by 109
- Verified
11-Oxygenated Androgens are Biomarkers of Adrenal Volume and Testicular Adrenal Rest Tumors in 21-Hydroxylase Deficiency
Turcu, A. F., Mallappa, A., Elman, M. S., Avila, N. A., Marko, J., Rao, H., Tsodikov, A., Auchus, R. J., & Merke, D. P. (2017) · The Journal of Clinical Endocrinology & Metabolism
Sexual Differentiation and DisordersAdrenal Hormones and Disorders
Cited by 107
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free